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Purpose: To evaluate the association of lysyl oxidase like 1 (LOXL1) gene variants in Japanese patients with open-angle
glaucoma.
Methods: We evaluated the association of three LOXL1 variants (rs1048661, rs3825942, and rs2165241) in 142 Japanese
patients with exfoliation syndrome (EX; n=59) and exfoliation glaucoma (EG; n=83) as well as in 251 control patients
aged 70 years or older with primary open-angle glaucoma (PG; n=40), normal tension glaucoma (NG; n=54), and cataract
(CT; n=157).
Results: In comparison with the CT group, the single nucleotide polymorphisms (SNPs) showed significant association
with EX, EG, and EX+EG. The odds ratio (OR)=19.71–28.23 and p=1.69x10−23-3.00x10−45 for allele T of rs1048661;
OR=28.21–39.78  and  p=1.77x10−8-2.42x10−22  for  allele  G  of  rs3825942;  and  OR=16.59–23.40  and
p=4.79x10−5-1.08x10−9  for  allele  C  of  rs2165241.  In  comparison  with  the  controls  (CT+PG+NG),  the  haplotype
rs1048661/rs3825942  (T/G)  was  significantly  associated  with  EX+EG  (p=8.27x10−44),  and  haplotype  G/A  had  a
significant protective effect (p=2.25x10−14). None of the three SNPs showed significant differences between the EX and
EG groups or between the PG and NG groups.
Conclusions: These SNPs are associated with exfoliation syndrome/glaucoma in the Japanese population. The risk alleles
in rs1048661 and rs2165241 are different from other populations. Additional genetic or environmental risk factors other
than these LOXL1 SNPs could be associated with the development of exfoliation syndrome as well as exfoliation glaucoma
among exfoliation syndrome patients.
Exfoliation syndrome is the most common identifiable
cause of open-angle glaucoma worldwide. It is an age-related,
generalized  disorder  of  the  extracellular  matrix  that  is
characterized by the production and progressive accumulation
of a fibrillar extracellular material in many ocular tissues [1].
A recent genome-wide association study demonstrated that
one  intronic  single  nucleotide  polymorphism  (SNP,
rs2165241) and two exonic SNPs (rs1048661 [R141L] and
rs3825942 [G153D]), which are located in the first exon of
the  lysyl  oxidase  like1  (LOXL1)  gene  on  chromosome
15q24.1, are highly associated with exfoliation syndrome in
Icelandic and Swedish populations while none of these SNPs
were associated with primary open-angle glaucoma in either
of the two populations [2].
Correspondence  to:  Takeshi  Iwata,  PhD,  National  Institute  of
Sensory Organs, National Hospital Organization, Tokyo Medical
Center, 2-5-2 Higashigaoka, Meguro-ku, Tokyo, 152-8902, Japan;
Phone:  +81-3-3411-1026;  FAX:  +81-3-3411-1026  email:
iwatatakeshi@kankakuki.go.jp.
Until  now,  several  lines  of  studies  have  reported
significant associations of these LOXL1 SNPs with exfoliation
syndrome [3-16] or the lack of associations of these SNPs with
primary open-angle glaucoma [16-18] in various populations.
In these studies, subjects in their 40s and 50s are sometimes
recruited as controls. The prevalence of clinical exfoliation
syndrome increases with age, particularly after the age of 60
years  [1].  However,  preclinical  exfoliation  syndromes  in
younger  generations  are  able  to  distinguish  from  normal
subjects until patients become older. Accordingly, the level of
statistical  significance  between  exfoliation  syndrome  and
controls  could  be  underestimated  in  studies  that  include
younger  patients  in  the  control  group.  In  this  study,  we
evaluated the association of three LOXL1 SNPs in Japanese
patients with exfoliation syndrome/glaucoma, primary open
angle glaucoma, normal tension glaucoma, and cataract. To
reduce the chance of misclassifying latent syndromes within
the control group, only patients aged 70 years or older were
recruited as primary open-angle glaucoma, normal tension
glaucoma, or cataract subjects in this study. To the best of our
knowledge, this is the first study reporting an association of
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1898LOXL1 SNPs with exfoliation syndrome/glaucoma using age-
controlled subjects. This is also the first study reporting the
association of LOXL1 SNPs with normal tension glaucoma.
METHODS
Subjects: Three hundred and ninety-three unrelated Japanese
subjects presenting exfoliation syndrome without glaucoma
(EX), exfoliation syndrome with glaucoma (EG), primary
open-angle glaucoma (PG), normal tension glaucoma (NG),
and cataract (CT) were recruited at the Shimane University
Hospital and Iinan Hospital in Shimane, Japan. This study
adhered to the tenets of the Declaration of Helsinki. The
research  was  reviewed  and  approved  by  the  Institutional
Review Boards of both hospitals. Written informed consent
was obtained from all of the subjects. All of the subjects
underwent  a  dilated  pupil  examination  of  the  anterior
segments, ocular media, and fundus using a slit-lamp and a
funduscope.  The  subjects  with  EX  and  EG  exhibited  the
typical pattern of exfoliation material on the anterior lens
surface and/or pupillary margin during slit-lamp examination.
The subjects with EG and PG had a history of intraocular
pressure (IOP) greater than or equal to 21 mmHg, and the
subjects with EX, NG, and CT had a history of IOP never
exceeding 20 mmHg. The subjects with PG, NG, and EG
presented a typical glaucomatous optic disc cupping or rim
thinning and visual field loss. The patients who had a history
of IOP greater than or equal to 21 mmHg but no glaucomatous
optic disc changes nor visual field loss were assigned as EG
in this study. To avoid possible misclassification of latent
exfoliation syndromes as PG, NG, or CT, patients younger
than 70 years old were not recruited. The number of subjects,
each gender, and the mean and range of ages in each group
are summarized in Table 1.
DNA  genotyping:  Genomic  DNA  was  extracted  from  the
peripheral white blood cells of each subject. Polymerase chain
reaction  (PCR)  was  performed  using  primers  designed  to
amplify the genomic region containing both rs1048661 and
rs3825942 (forward primer: 5′-AGG TGT ACA GCT TGC
TCA ACT C-3′ and reverse primer: 5′-TAG TAC ACG AAA
CCC TGG TCG T-3′) or just rs2165241 (forward primer: 5′-
AGA ATG CAA GAC CTC AGC ATG AG-3′ and reverse
primer: 5′-TAG TGG CCA GAG GTC TGC TAA G-3′). The
sequence was determined based on the dideoxy terminator
method  using  an  ABI  PRISM  3130xl  Genetic  Analyzer
(Applied  Biosystems,  Foster  City,  CA)  according  to  the
manufacturer’s protocol. We used SeqScape Software version
2.5 (Applied Biosystems) to analyze the sequence alignment.
Statistical  analysis:  The  deviation  of  the  genotype
distributions  from  the  Hardy–Weinberg  equilibrium  was
assessed  in  the  case  and  control  samples  using
HAPLOVIEW  version  4.0  [19].  Statistical  analysis  was
performed using R version 2.6.2. Fisher’s exact test was used
to compare the allele or genotype frequencies of each case
group  with  the  controls.  The  odds  ratio  (OR)  and  95%
confidence  intervals  (CIs)  were  calculated  by  the  logistic
regression method. Individual haplotypes and their estimated
population frequencies were inferred using HAPLOVIEW
version 4.0 [19] with all of the parameters set at the default
values.
RESULTS
The allelic and genotypic counts and frequencies of SNPs
rs1048661,  rs3825942,  and  rs2165241  within  LOXL1  are
shown in Table 2. The ORs and p values for the allelic and
genotypic  frequencies  of  the  three  SNPs  in  comparison
between the cases (EX, EG, and EX+EG) and controls (CT,
PG, NG, and PG+NG) are shown in Table 3. In comparison
with the CT group, the SNPs showed a significant association
with EX, EG, and EX+EG for the T allele of rs1048661 at
OR=19.71–28.23 and p=1.69x10−23-3.00x10−45, the G allele
of  rs3825942  at  OR=28.21–39.78  and
p=1.77x10−8-2.42x10−22,  and  the  C  allele  of  rs2165241  at
OR=16.59–23.40 and p=4.79x10−5-1.08x10−9 (Table 3). The
genotypes, TT of rs1048661 (p=4.11x10−25-3.78x10−43), GG
of  rs3825942  (p=3.53x10−11-2.10x10−33),  and  CC  of
rs2165241 (p=1.95x10−4-1.07x10−8), also showed significant
TABLE 1. SUMMARY OF STUDY POPULATIONS.
Parameter
Exfoliation syndrome or glaucoma Primary glaucoma
CT p value EX EG                       EX+EG PG NG PG+NG
No. of subjects 59 83 142 40 54 94 157
Male:Female
N 12:47 42:41 54:88 14:26 18:36 32:62 45:112 0.2264*
% 20.3:79.7 50.6:49:4 50.6:49:4 35.0:65.0 33.3:66.7 34.0:66.0 28.7:71.3
Age (years)
mean±SD 78.2±8.0 78.8±8.5 78.5±8.2 75.6±5.3 78.3±4.8 77.2±5.1 77.2±5.0 0.1271**
Range 55–95 57–95 55–95 70–87 70–91 70–91 70–90
The asterisk and double asterisk indicate that the p values were obtained by Pearson's χ2 test and one-way ANOVA, respectively,
among three (EX+EG, PG+NG, and CT) groups. EX, exfoliation syndrome; EG, exfoliation glaucoma; PG, primary open-angle
glaucoma aged 70 years or older; NG, normal tension glaucoma aged 70 years or older; CT, cataract aged 70 years or older.
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1901associations  with  EX,  EG,  and  EX+EG  when  they  were
compared to the CT group (Table 2 and Table 3). Significant
associations  with  EX,  EG,  and  EX+EG  were  detected  in
comparisons with the primary glaucoma groups (PG, NG, and
PG+NG) for the alleles, T of rs1048661, G of rs3825942, and
C of rs2165241, as well as the genotypes, TT of rs1048661,
GG of rs3825942, and CC of rs2165241, with the exception
of the comparisons between EX, EG, or EX+EG and the PG
groups for allelic (OR=4.56–6.43 and p=0.3051–0.0729) and
genotypic  (p=0.3000–0.0715)  frequencies  in  rs2165241
(Table 3).
None of the three SNPs showed a significant difference
between the EX and EG groups in these allelic or genotypic
frequencies (Table 4). In addition to this, none of the three
SNPs  showed  significant  differences  in  their  allelic  or
genotypic frequencies in comparisons between the primary
glaucoma (PG, NG, or PG+NG) and CT groups or between
the PG and NG groups (data not shown), excepted for the
allele C of rs2165241 (p=0.0233) and the genotype CC of
rs2165241 (p=0.0294) in comparison between the PG and NG
groups.
The  two  SNPs,  rs1048661  and  rs3825942,  were  in
linkage disequilibrium (D’=1). In our study populations, only
three  of  the  four  possible  haplotypes  in  rs1048661/
rs3825942  were  detected  (Table  5  and  Table  6).  In  the
comparisons between cases (EX, EG, or EX+EG) and controls
(CT+PG+NG), the T and G were significantly associated with
EX, EG, and EX+EG, and the G and A had a significant
protective effect (Table 5 and Table 6).
DISCUSSION
Based on this study among 393 elderly Japanese patients with
exfoliation syndrome, exfoliation glaucoma, primary open-
angle glaucoma, and cataract, we confirmed the findings of
Thorleifsson  and  colleagues  [2]  that  three  SNPs  within
LOXL1 are strongly associated with exfoliation syndrome and
glaucoma. In addition to the original study in Icelandic and
Swedish  populations,  allele  G  of  rs3825942  has  been
consistently  suggested  as  a  risk–associated  allele  of
exfoliation  syndrome/glaucoma  in  five  studies  from  the
United States [3-7], two studies from Europe [8,9], one study
from India [10], one study from Australia [11], and six studies
including this one from Japan [12-16]. In this study, we found
that  allele  T  of  rs1048661  is  associated  with  exfoliation
syndrome/glaucoma, which is consistent with other studies in
the Japanese population [12-16], while allele G is reported to
be risk-associated in studies from other countries [2-4,6-11].
We also found that allele C of rs2165241 is associated with
exfoliation syndrome/glaucoma, which is consistent with one
study from Japan [13], while allele T is risk-associated in other
populations [2,4,5,7,8]. Allelic frequencies of the three SNPs
reported  in  previous  studies  and  the  current  study  are
summarized in Figure 1. These results suggest a possibility
that the missense changes in LOXL1 are not actually causative
but mark a haplotype that carries variants that may indeed be
causative.
This study revealed extremely high ORs and significant
p values for the three SNPs in the comparisons between the
exfoliation syndrome/glaucoma groups and cataract groups.
Only patients aged 70 years or older were recruited as control
subjects in this study, enabling us to reduce the chance of
misclassifying latent or preclinical exfoliation syndromes into
the control group. Accordingly, the inclusion criteria of the
control group might contribute to the extremely significant
association of the LOXL1 SNPs with exfoliation syndrome in
this study. In contrast, the significance of the association of
the SNPs with exfoliation syndrome/glaucoma was relatively
low when the PG group was used as a control comparison
compared to when the NG or CT groups were used as control
comparisons. Although the level of significance was relatively
low, we found differences in frequencies between PG and NG
for allele C of rs2165241 (p=0.0233) and the genotype CC of
rs2165241  (p=0.0294).  These  may  suggest  the  possible
inclusion of late onset exfoliation syndrome in the PG group.
Previously,  a  lack  of  association  between  LOXL1
polymorphisms and primary open-angle glaucoma or primary
angle-closure glaucoma were reported in Caucasian, African
American, Ghanaian, and Indian populations [17,18]. We did
TABLE 4. ODDS RATIOS AND P VALUES FOR THREE SNPS IN COMPARISON BETWEEN EX AND EG.
  EX versus EG
rs1048661 rs3825942 rs2165241
Allele
p value 0.5829 1 1
OR 1.43 1.41 1.41
95% CI 0.49–4.20 0.09–22.78 0.09–22.78
Genotype
p value 0.2005 1 1
No significant association was found between EX and EG. OR, odds ratio; CI, confidence interval; EX, exfoliation syndrome;
and EG, exfoliation glaucoma. p values were obtained by Fisher's exact probability test.
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1903not find any significant associations between any of the three
SNPs with primary open-angle glaucoma, reconfirming the
previous  observations  in  our  Japanese  population.  Most
recently, one study from Japan reported a lack of association
between  LOXL1  polymorphisms  and  primary  open-angle
glaucoma  in  two  of  three  SNPs  (e.g.,  rs1048661  and
rs3825942) [16]. In addition to this, the current study suggests
a lack of association between rs2165241 and primary open-
angle glaucoma as well as a lack of association between any
of the three SNPs with normal tension glaucoma.
In  this  study,  none  of  the  SNPs  exhibited  significant
differences in their allelic and genotypic frequencies between
exfoliation syndrome and glaucoma, suggesting that these
SNPs are associated with exfoliation glaucoma through their
association with exfoliation syndrome as reported previously
[2]. Accordingly, our data suggest that additional genetic or
environmental  risk  factors  are  associated  with  the
development  of  exfoliation  glaucoma  among  exfoliation
syndrome patients. Further study is required to clarify these
risks.
In  summary,  we  have  demonstrated  significant
associations of LOXL1 variants with Japanese patients who
have  exfoliation  syndrome/glaucoma.  Compared  to  other
populations, the risk alleles in rs1048661 and rs2165241 are
unique  in  this  population.  The  LOXL1  association  of
exfoliation glaucoma is through the association of exfoliation
syndrome. LOXL1 lacked any association with primary open-
angle  glaucoma  or  normal  tension  glaucoma  in  this
population. Additional genetic or environmental risk factors
Figure 1. Allelic frequencies of the three SNPs reported in previous
studies and the current study. Allelic frequencies of three SNPs in
cases (exfoliation syndrome and exfoliation glaucoma) and controls
(cataract or normal population) that have been reported in literatures
are summarized.
TABLE 6. P VALUES FOR HAPLOTYPE RS1048661/RS3825942 IN COMPARISONS BETWEEN CASES (EX, EG, AND EX+EG) AND CONTROLS (CT, NG, PG+NG,
CT+NG, AND CT+PG+NG).
  EX
Versus
CT
Versus
   NG
Versus
PG+NG
Versus
CT+NG
Versus
CT+PG+NG
TG 9.56x10-21 NA 9.56x10-21 6.19x10-17 1.27x10-21
GG 9.69x10-11 NA 9.69x10-11 1.76x10-10 1.43x10-10
GA 1.01x10-6 NA 1.01x10-6 5.63x10-7 5.63x10-7
  EG
Versus
CT
Versus
NG
Versus
PG+NG
Versus
CT+NG
Versus
CT+PG+NG
TG 1.83x10-28 4.95x10-21 3.06x10-23 9.77x10-30 4.40x10-20
GG 3.12x10-15 2.51x10-11 4.82x10-12 2.60x10-15 3.70x10-15
GA 5.63x10-9 8.10x10-9 4.08x10-9 3.02x10-9 2.36x10-9
  EX+EG
Versus
CT
Versus
NG
Versus
PG+NG
Versus
CT+NG
Versus
CT+PG+NG
TG 1.23x10-40 7.84x10-29 1.24x10-32 5.89x10-43 8.27x10-44
GG 5.93x10-22 4.01x10-15 1.03x10-16 2.39x10-22 2.83x10-22
GA 1.17x10-13 3.98x10-13 9.33x10-14 3.68x10-14 2.25x10-14
Significant association was found between cases and controls. EX, exfoliation syndrome; EG, exfoliation glaucoma; PG, primary
open  angle glaucoma aged 70 years or older; NG, normal tension glaucoma aged 70 years or older; and CT, cataract aged 70
years or older. NA, not available due to a small number of samples.
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1904other than LOXL1 are likely to be associated with an increase
in exfoliation glaucoma among exfoliation syndrome patients.
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